Zdrowie i gospodarka · 21/09/2016

FDA Releases Draft Guidance on Risk Evaluation and Mitigation Strategies

The Food and Drug Administration (FDA) has published a draft guidance outlining its process for determining when a risk evaluation and mitigation strategy (REMS) is necessary to ensure a drug's benefits outweigh its risks, in line with the Prescription Drug User Fee Act V.